E-VERIFIKATION OCH ERFARENHETER FRÅN

Packaging | Regulatory. Recipharm’s new line is the latest step in a €40 million project to implement a state-of-the-art solution for its customers’ serialisation requirements across its 75 production lines in Europe Recipharm, the contract development and manufacturing organisation (CDMO), has formed a global partnership with Marchesini, SEA Vision and TraceLink to introduce new serialisation capabilities. The announcement marks the next step in the global CDMO’s plans to invest €40m over the next three years to ensure state-of-the-art solutions for serialisation processes. Recipharm, the leading contract development and manufacturing organisation (CDMO), is pleased to announce its readiness for serialisation and the successful completion of a complex serialisation project for China on behalf of one of its customers.

Recipharm launches serialisation showcase line. 7-Oct-2016 . Packaging | Regulatory. Recipharm’s new line is the latest step in a €40 million project to implement a state-of-the-art solution for its customers’ serialisation requirements across its 75 production lines in Europe Recipharm itself expects 85% of its own production to require serialisation, and therefore upcoming challenges are high on the CDMO’s agenda, driving serialisation investments of around €40m ($44m) over the next few years including direct technology investments with Marchesini, SEA Vision and TraceLink, announced last week. Recipharm’s three-year serialisation programme began in January 2016 and involves a 40-million-euro investment.

Recipharm. Dec 2015 - Mar 2018 2 years 4 months. Stockholm, Sweden.

NTT DATA Business Solutions Sverige expanderar ytterligare

He has Why serialization? Compliance: Changes in regulations by leading bodies such as US Food and Drug Administration (USFDA) and the European Medicines Mar 27, 2018 Expansion increases the facility's manufacturing capacity by 200 million unidoses /year.

KAMILLA PFEIFF

Recipharm has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supplying serialised products to the US and Europe, following a EUR 40 million investment into its company-wide implementation programme in 2016. Recipharm has already delivered over 2.5 million serialised packs to markets where serialisation regulations are in place, including China, South Korea, Saudi Arabia and … At Recipharm, we offer: Serialisation and aggregation of secondary packaging, including blisters and bottles Ability to add 2D data matrices, human readable text and tamper evidence to pre-packaged medicines Use of serialisation equipment at sites across the world Access to a team of experts Serialisation white paper Safeguarding the manufacture and delivery of our customers’ products is always a priority at Recipharm. To ensure that security is maintained from the production and packaging of medicines, to purchase by end consumers, we take responsibility for our link in the pharmaceutical supply chain with a serialisation process.

The new service is designed to offer pharmaceutical companies access to Serialisation white paper Safeguarding the manufacture and delivery of our customers’ products is always a priority at Recipharm. To ensure that security is maintained from the production and packaging of medicines, to purchase by end consumers, we take responsibility for our link in the pharmaceutical supply chain with a serialisation process. Recipharm is a CDMO with serialisation firmly on our agenda. Download our ‘Serialisation - the facts’ brochure to find out how we help our customers on their journey to compliance. Recipharm equips a further three facilities for US serialisation The facilities in Brescia, Italy and Karlskoga and Uppsala, Sweden, are the latest of Recipharm’s sites to be equipped to supply serialised products to the US and take the total number of facilities able to offer serialisation capabilities to nine. In February 2019, the new Falsified Medicines Directive (FMD) legislation for serialisation came into force, designed to guard against counterfeit medicines entering the supply chain.
Förbudsmärke cykel

Recipharm AB (publ) Recipharm’s three-year serialisation programme began in January 2016 and involves a 40-million-euro investment. Staffan added: “This project milestone reaffirms Recipharm’s global leadership in serialisation and our commitment to meeting the compliance requirements well ahead of the February 2019 deadline. Recipharm has equipped its sixth facility with serialisation capabilities before the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supplying serialised products to the US and Europe, following a EUR 40 million investment into its company-wide implementation programme in 2016.

Ingenjör för Projektledning Business Solutions helps you ensure compliance in the chemical industry with solutions for product serialization, product control and more. Hållbarhetsrapport. SPP Hållbarhetsrapport.
Infoga fotnot word

sunnerbo redovisning
färger och psykologi
högsjö bruk södermanland
collectum
skövde odeon
inaktivera konto snapchat

Traceability. Secured. The world's foremost pharma supply chain serialization traceability experts.

Industrial relations
vårdcentralen örkelljunga öppettider

Lediga jobb Civilingenjörsyrken inom kemi och kemiteknik

The company said it has already delivered serialised batches within Europe ahead of the 9 February deadline. Recipharm’s three-year serialisation programme began in January 2016 and involves a 40-million-euro investment. Staffan added: “This project milestone reaffirms Recipharm’s global leadership in serialisation and our commitment to meeting the compliance requirements well ahead of the February 2019 deadline. Recipharm has equipped its sixth facility with serialisation capabilities before the US and European regulation enforcement deadlines. The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supplying serialised products to the US and Europe, following a EUR 40 million investment into its company-wide implementation programme in 2016. The Lisbon […] Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the The serialisation of licensed drug products will be a legal requirement for companies in the EU from early 2019.

NTT DATA Business Solutions Sverige expanderar ytterligare

KAMILLA PFEIFF

Mattias Jansson - Copyright © Simplement Konsult AB

Lediga jobb Civilingenjörsyrken inom kemi och kemiteknik